enprofylline has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Misso, NL; Thompson, PJ | 1 |
| Erjefält, I; O'Donnell, SR; Persson, CG | 1 |
2 other study(ies) available for enprofylline and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Xanthines inhibit human platelet aggregation induced by platelet-activating factor.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Theophylline; Xanthines | 1992 |
Early and late tracheobronchial plasma exudation by platelet-activating factor administered to the airway mucosal surface in guinea pigs: effects of WEB 2086 and enprofylline.
Topics: Animals; Azepines; Bronchi; Capillary Permeability; Guinea Pigs; Male; Mucous Membrane; Platelet Activating Factor; Trachea; Triazoles; Xanthines | 1990 |